• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ENBF2816C145EE
Device Problem Material Integrity Problem (2978)
Patient Problem Insufficient Information (4580)
Event Date 03/13/2024
Event Type  Injury  
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
An endurant stent graft was implanted during the emergent endovascular treatment of a threatened ruptured 70mm aaa.No approach stenosis or calcified thrombus was found in preoperative examination.It was reported during the index procedure the physician activated the hydrophilic coating however it was difficult to insert the stent graft.The delivery system was withdrawn and the hydrophilic coating was activated again.The stent was deployed after a difficult delivery.Difficulties were then encountered when attempting to withdraw the delivery system and the physician was unable to withdraw due to a suspected vasospasm in the patient.After the anesthesiologist administered medication the physician waited 15 minutes before withdrawing the delivery system successfully.Per the physician the cause was due to the failure of the hydrophilic coating on the device.No additional sequelae were reported and the patients is fine.
 
Manufacturer Narrative
Device evaluation summary: device decontaminated with cidex-opa pending further device testing to support the final product analysis findings.The delivery system returned for analysis with the external slider open and graft cover fully retracted.No difficulty was experienced advancing and retracting the graft cover.Blood was visible on the backend wheel screw gear threads, and the while had partially skipped off the threads.Additional decontamination was performed to remove excess blood and the backend wheel was removed.Excessive stress marks were visible on the wheel tabs with no deformation noted to the dowels.Severe damage was observed to the screw gear threads underneath the backend wheel.The handle was disassembled and the middle member lock components, stent stop t-tube and strain relief were confirmed as 20f size.The reported coating issue could not be confirmed through analysis.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT BIFURCATED STENT GRAFT
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18985593
MDR Text Key338685980
Report Number9612164-2024-01476
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P100021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/27/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberENBF2816C145EE
Device Catalogue NumberENBF2816C145EE
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/13/2024
Initial Date FDA Received03/27/2024
Supplement Dates Manufacturer Received05/07/2024
Supplement Dates FDA Received05/27/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/03/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-